Acute effects of empagliflozin on left atrial and ventricular filling parameters using echocardiography—a subanalysis of the EMPAG-HF trial
Immediate addition of empagliflozin to standard therapy improves echocardiographic parameters of LAV in patients following recompensation of ADHF.
Authors
- Julian Westphal (ORCID: https://orcid.org/0000-0002-7488-4000)
- Paul Christian Schulze (ORCID: https://orcid.org/0000-0001-9442-7141)
- Sissy Grund
- Pawel Aftanski (ORCID: https://orcid.org/0000-0002-4828-663X)
- Ali Hamadanchi
- Franz Haertel (ORCID: https://orcid.org/0000-0002-4883-5176)
- Martin Busch (ORCID: https://orcid.org/0000-0002-7889-6156)
- Tiến Dũng Nguyễn (ORCID: https://orcid.org/0000-0001-9347-1511)
- Jürgen Bogoviku
- Sven Moebius‐Winkler
Institutions
- Friedrich Schiller University Jena (DE)
Publication Details
- Journal
- European Heart Journal - Cardiovascular Pharmacotherapy
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1093/ehjcvp/pvaf003
- Citations
- 8
- Primary Topic
- Cardiovascular Function and Risk Factors
- Type
- article
- Field-Weighted Citation Impact
- 11.11
Funders
- Boehringer Ingelheim